Mri Measures of Neurodegeneration as Biomarkers of Alzheimer’s Disease
نویسندگان
چکیده
s and Poster PresentationsRisacher SL, Yoder KK, West JD, WuDunn D, MaGee TR, McDonald BC,Hutchins GD, Zheng QH, Saykin AJ. Relationship of visual contrast sensitivity toamyloid deposition assessed by [11C] PiB PET. Accepted for poster presentation at the Human Amyloid Imaging Conference, January 12-13, 2012. Wang H, Nie F, Huang H, Risacher SL, Ding C, Saykin AJ, Shen L, and theAlzheimer’s Disease Neuroimaging Initiative (ADNI). Sparse multi-taskregression and feature selection to identify brain imaging predictors for memoryperformance. Accepted for poster presentation at the International Conference on Computer Vision, November 6-13, 2011. Nho K, Shen L, Kim S, Swaminathan S, Risacher SL, Saykin AJ, and theAlzheimer’s Disease Neuroimaging Initiative (ADNI). The effect of referencepanels and software tools on genotype imputation. Presented at the 2011 American Medical Informatics Association Annual Symposium, October 22-25,
منابع مشابه
The most valuable biomarkers of Alzheimer\'s disease: a review article
Alzheimer’s disease (AD) is the most popular type of dementia in elderly and is described by a progressive loss of cognitive capacity and severe neurodegeneration which typically begins with memory deficits. The major biomarkers of AD include total tau, phosphorylated-tau and 42 amino acid isoform of amyloid beta that reflect neurodegeneration and indicate the pathophysiological processes in AD...
متن کاملThe Participation of Three Brain Tissues in Alzheimer’s disease Diagnosis from Structural MRI
Alzheimer’s disease (AD) is a progressive and irreversible disease which gradually makes patients unable to do their daily routines. Although the present treatments can not cure the disease completely, its early detection can reduce symptoms and enhance the patients’ life quality. In the current literature, using the grey matter (GM) tissue which is known as an appropriate biomarker is highly c...
متن کاملOverestimating the Effects of Healthy Aging
Typical cognitive aging is often defined as aging free of dementia, and yet it does not seem to exclude dementia-related pathology. The most common type of dementia is Alzheimer’s disease (AD) – it is a progressive neurodegenerative disease that affects multiple cognitive domains, including memory, attention, reasoning, judgment, language, as well as behavior. AD accounts for 60–80% of dementia...
متن کاملGlobal gene expression analysis using microarray to study differential vulnerability to neurodegeneration
Neurodegenerative disorders such as Parkinson’s disease, motor neuron disease and Alzheimer’s disease is characterized by loss of specific cells within certain regions of the brain. One of the most compelling questions is to determine why specific cell populations are vulnerable to neurodegeneration. We addressed this question by studying global gene expression changes using an animal model of ...
متن کاملHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Currently available evidence strongly supports the position that the initiating event in Alzheimer's disease (AD) is related to abnormal processing of beta-amyloid (Abeta) peptide, ultimately leading to formation of Abeta plaques in the brain. This process occurs while individuals are still cognitively normal. Biomarkers of brain beta-amyloidosis are reductions in CSF Abeta(42) and increased am...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2011